Solventum Corporation announced the pricing of a secondary offering of 8,800,000 shares of its common stock.
The offering is expected to result in gross proceeds of approximately $648 million to the Selling Shareholder, 3M Company.
The Company will not receive any proceeds from this secondary offering, with all shares being sold by the Selling Shareholder.
Offering Details
8,800,000 shares of common stock offered resulting in gross proceeds of $648 million to 3M Company.
Underwriters
Goldman Sachs & Co. LLC and BofA Securities are acting as the underwriters for the offering.
Registration Statement
Offering made under the Company's shelf registration statement on Form S-3 filed with the SEC on Aug. 13, 2025.
- The secondary offering is a strategic move to generate significant funds for the Selling Shareholder, 3M Company.
- Solventum Corporation's decision not to receive any proceeds indicates the Company's focus on shareholder value and financial planning.
The pricing of the secondary offering marks a significant financial transaction for Solventum Corporation. The involvement of reputable underwriters and the expected gross proceeds highlight the market's confidence in the Company's potential.